Navigation Links
First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

eric equivalents, the extent to which Teva may obtain U.S. market exclusivity for certain of its new generic products and regulatory changes that may prevent Teva from utilizing exclusivity periods, competition from brand-name companies that are under increased pressure to counter generic products, or competitors that seek to delay the introduction of generic products, the impact of consolidation of our distributors and customers, potential liability for sales of generic products prior to a final resolution of outstanding patent litigation, including that relating to the generic versions of Allegra(R) and Neurontin(R), the effects of competition on our innovative products, especially Copaxone(R) sales, the impact of pharmaceutical industry regulation and pending legislation that could affect the pharmaceutical industry, the difficulty of predicting U.S. Food and Drug Administration, European Medicines Agency and other regulatory authority approvals, the regulatory environment and changes in the health policies and structures of various countries, our ability to achieve expected results though our innovative R&D efforts, Teva's ability to successfully identify, consummate and integrate acquisitions, potential exposure to product liability claims to the extent not covered by insurance, dependence on the effectiveness of our patents and other protections for innovative products, significant operations worldwide that may be adversely affected by terrorism, political or economical instability or major hostilities, supply interruptions or delays that could result from the complex manufacturing of our products and our global supply chain, environmental risks, fluctuations in currency, exchange and interest rates, and other factors that are discussed in Teva's Annual Report on Form 20-F and its other filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligati
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
(Date:4/17/2015)... Apr. 16, 2015 Research and Markets ... "Corporate Reputation of Pharma in 2014 - a ... report to their offering. This independent study, ... patient groups with an interest in diabetes on the ... the pharma industry as a whole) in 2014. The ...
(Date:4/17/2015)... , Apr. 16, 2015 Research and Markets ... the "Corporate Reputation of Pharma in 2014 - ... Edition" report to their offering. For ... opinions on the corporate reputation of the pharmaceutical industry ... health with the views of patient organisations representing all ...
(Date:4/17/2015)... TAIPEI , April 17, 2015 TWi ... fully-owned subsidiary, TWi Pharmaceuticals USA , ... in the United States.  It has been in close ... wholesalers and expects to have its own label specialty ... soon in the U.S. pharma market. According ...
Breaking Medicine Technology:Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3
... Genomic Health , Inc. (Nasdaq: GHDX ... Financial Officer, will present at the 31st Annual Canaccord ... 2011 at 11:30 a.m. Eastern Time (ET).   ... of the presentation, visit the Investor Relations section of ...
... 2011 It,s back-to-school season and for many families, ... To view the multimedia assets associated with ... (Photo: http://photos.prnewswire.com/prnh/20110804/MM45457 ) Each ... U.S. are infested with this common, six-legged critter that ...
Cached Medicine Technology:Genomic Health to Present at the Canaccord Genuity Growth Conference 2Head Lice Returns to School: Five Tips to Avoid Panic and Worry 2
(Date:4/19/2015)... 2015 HealthPostures, LLC , a ... will exhibit it’s pioneering ergonomics products at the Wisconsin ... Safety Council Professional Development Conference and Expo . The ... are used in volume by call centers, educational organizations, ... to clamp to a desk, the TaskMate Go 6350 ...
(Date:4/18/2015)... April 18, 2015 Carinsurancesavings.biz has released ... plans are cheaper during Spring. , Spring ... insurance plan. Drivers should make sure they compare the ... vehicles. Clients can learn more about Spring car insurance ... , Auto insurance quotes are becoming more and more ...
(Date:4/18/2015)... Insuranceautoquote.info has released a new blog post explaining how ... , Clients can review important auto insurance quotes online, ... important advantages for clients who need affordable financial security ... have coverage for their vehicles can purchase a policy ... Many agencies offer important discounts and drivers can learn ...
(Date:4/18/2015)... the past few weeks, TheBeautyPlace.com has been undergoing maintenance ... run maintenance on our shipping facilities to update software ... Director. "It disrupted our regular shipping schedule but we ... track after having completed the maintenance." , Now, TheBeautyPlace.com ... has not allowed some calls to come in through ...
(Date:4/18/2015)... PHOENIX, ARIZONA – In March, Mark Ona, Territory ... destruction professionals across the United States, earned the professional ... display “CSDS” as a professional title with his name. ... of Information Destruction 2015 Annual Conference began - one ... 20 people who took the exam, Ona was amongst ...
Breaking Medicine News(10 mins):Health News:HealthPostures' TaskMate Products to be Exhibited at the Wisconsin and Iowa-Illinois Safety Conferences 2Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:TheBeautyPlace.com Temporary Number Available 2
... generic drug approval process; provide more options ... for consumers, health professionals, WASHINGTON, ... a program aimed at increasing the number and,variety of generic ... generally cost less than their brand-name,counterparts and competition among generics ...
... canola,oil for common dietary fats in the U.S. ... and plant omega-3 fats,noted a modeling study published ... the American Dietetic Association (JADA). The study examined ... oils and canola oil-based,margarine for other margarines and ...
... has joined Microsoft Corp. in a,strategic relationship ... consumer health platform. In this relationship, ... Diet.com Weight Tracker, and Diet.com Blood,Glucose Tracker, ... will,enable users to share information with physicians, ...
... 4 AmeriCares and,International Medical Corps (IMC) are ... responding to the cholera outbreak in that country. ... diarrhea have spread,through northern Iraq recently, affecting some ... in Baghdad at the end of September.,According to ...
... Applications Lead to Texas Children,s ... ... developer of the,OnBase enterprise content management (ECM) software suite, has ... provider,for document management. (Logo: http://www.newscom.com/cgi-bin/prnh/20070110/CLW019LOGO ) ...
... people are bitten again by ticks , THURSDAY, Oct. 4 ... relapse of Lyme disease may actually have been bitten by ... new study suggests. , "It is striking how often re-infection ... of medicine at New York Medical College, said in a ...
Cached Medicine News:Health News:FDA Announces Initiative to Bolster Generic Drug Program 2Health News:Canola Oil Can Help Americans Meet Dietary Fat Recommendations 2Health News:Diet.com Enters Strategic Collaboration To Support Microsoft HealthVault 2Health News:AmeriCares and International Medical Corps Airlift Relief for Cholera Outbreak In Iraq 2Health News:AmeriCares and International Medical Corps Airlift Relief for Cholera Outbreak In Iraq 3Health News:Texas Children's Hospital Selects Hyland Software's OnBase to Complete Electronic Medical Records Initiative 2Health News:Texas Children's Hospital Selects Hyland Software's OnBase to Complete Electronic Medical Records Initiative 3Health News:Lyme Disease Relapse Often a New Infection 2
Grab one and go, One of the smallest handheld oximeters available, Datex-Ohmeda s TuffSat is the ideal spot-check solution for hospital, home care, transport, and EMS. TuffSat comes fully loaded wi...
The GEM OPL CO-Oximeter provides comprehensive oxygenation status in an easy-to-use, portable manner. The GEM OPL is the ideal solution for laboratory or point-of-care CO-Oximetry testing....
Maxi-Therm® hyper-hypothermia water blankets from Cincinnati Sub-Zero are designed for single-patient use. These blankets are easy to clean, stain resistant and ideal for isolation cases....
... blankets are the most durable out of ... is formed with durable urethane. These blankets ... that of most competitive plastic blankets. Blood, ... surface. Set-up is also simplified through the ...
Medicine Products: